We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+2.84%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$37.8B
AUM Growth
+$858M
Cap. Flow
+$54.1M
Cap. Flow %
0.14%
Top 10 Hldgs %
5.01%
Holding
2,954
New
116
Increased
1,159
Reduced
1,473
Closed
125

Top Buys

Rank Stock Value
1
IT icon
Gartner
IT
+$57.5M
2
ALGN icon
Align Technology
ALGN
+$53.5M
3
DXC icon
DXC Technology
DXC
+$51.9M
4
ANSS
Ansys
ANSS
+$46.1M
5
EG icon
Everest Group
EG
+$34.5M

Sector Composition

Rank Sector Weight
1 Technology 13.9%
2 Financials 12.99%
3 Healthcare 12.28%
4 Industrials 11.03%
5 Consumer Discretionary 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KNDI
2726
Kandi Technologies Group
KNDI
$67.5M
$53K ﹤0.01%
11,994
-291
-2% -$1.2K
MNOV icon
2727
MediciNova
MNOV
$65.5M
$53K ﹤0.01%
10,241
+36
+0.4% +$202
IPI icon
2728
Intrepid Potash
IPI
$456M
$52K ﹤0.01%
2,324
+297
+15% +$6.22K
ASG
2729
Liberty All-Star Growth Fund
ASG
$328M
$50K ﹤0.01%
+10,224
New +$48.3K
NOG icon
2730
Northern Oil and Gas
NOG
$2.3B
$50K ﹤0.01%
3,548
+1,371
+63% +$26.5K
PXLW icon
2731
Pixelworks
PXLW
$38.2M
$48K ﹤0.01%
+873
New +$51.3K
CDMO
2732
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$46K ﹤0.01%
10,755
AVEO
2733
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$46K ﹤0.01%
2,050
CLDX icon
2734
Celldex Therapeutics
CLDX
$2.99B
$44K ﹤0.01%
1,235
-197
-14% -$8.71K
III icon
2735
Information Services Group
III
$199M
$44K ﹤0.01%
10,767
-19
-0.2% -$68
JMEI
2736
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
$44K ﹤0.01%
2,062
-52
-2% -$1.59K
CVRS
2737
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$43K ﹤0.01%
23,249
+796
+4% +$1.06K
RSYS
2738
DELISTED
Radisys Corp
RSYS
$43K ﹤0.01%
11,439
-32
-0.3% -$125
DXLG icon
2739
Destination XL Group
DXLG
$31.2M
$41K ﹤0.01%
17,450
-1,208
-6% -$2.96K
VVUS
2740
DELISTED
Vivus Inc
VVUS
$41K ﹤0.01%
3,346
GRPN icon
2741
Groupon
GRPN
$1.05B
$40K ﹤0.01%
+532
New +$36.9K
TLRA
2742
DELISTED
Telaria, Inc.
TLRA
$39K ﹤0.01%
15,615
PLX icon
2743
Protalix BioTherapeutics
PLX
$191M
$34K ﹤0.01%
4,064
QUIK icon
2744
QuickLogic
QUIK
$232M
$34K ﹤0.01%
+1,643
New +$33.3K
WG
2745
DELISTED
Willbros Group
WG
$34K ﹤0.01%
13,753
-68
-0.5% -$173
FATE icon
2746
Fate Therapeutics
FATE
$286M
$33K ﹤0.01%
+10,300
New +$39.5K
LEE icon
2747
Lee Enterprises
LEE
$172M
$32K ﹤0.01%
1,670
LITS
2748
Lite Strategy Inc
LITS
$32.8M
$32K ﹤0.01%
674
IVE icon
2749
iShares S&P 500 Value ETF
IVE
$49B
$31K ﹤0.01%
299
-936
-76% -$97.5K
FUEL
2750
DELISTED
Rocket Fuel Inc.
FUEL
$31K ﹤0.01%
11,337
+1,108
+11% +$4.14K

Similar funds

Guggenheim Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Guggenheim Capital held 2,954 positions worth $37.8B, up 2.3% from $36.9B the previous quarter. Its ten largest holdings account for 5% of the portfolio.

Guggenheim Capital's Q2 2017 filing shows 116 new, 1,159 increased, 1,473 reduced and 125 closed positions. Its largest new stake was DXC Technology: 781,396 shares worth $51.9M. The largest sale was Yahoo Inc, an estimated $55.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Guggenheim Capital's largest Q2 2017 buy was DXC Technology: 781,396 shares worth $51.9M.
  • Guggenheim Capital added most to Gartner in Q2 2017, an estimated $57.5M increase.
  • Guggenheim Capital's biggest Q2 2017 reduction was Teradata, cutting an estimated $40.2M.
  • Guggenheim Capital fully exited Yahoo Inc in Q2 2017, selling an estimated $55.8M.
  • Guggenheim Capital's ten largest holdings make up 5% of its $37.8B portfolio in Q2 2017.
  • Guggenheim Capital opened 116 new positions and closed 125 in Q2 2017.
  • Guggenheim Capital's portfolio value rose 2.3% quarter-over-quarter to $37.8B.

Based on Guggenheim Capital's 13F filing for Q2 2017, filed 14 Aug 2017.